ACLS(ACLS)
ACLS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $844M | $925M | $1.03B |
| Low | $842M | $902M | $1.01B |
| High | $846M | $949M | $1.06B |
| EBITDA Avg | $194M | $213M | $237M |
| Low | $193M | $207M | $231M |
| High | $194M | $218M | $243M |
| EBIT Avg | $181M | $198M | $221M |
| Low | $181M | $193M | $216M |
| High | $181M | $203M | $227M |
| Net Income Avg | $122M | $151M | $159M |
| Low | $117M | $141M | $154M |
| High | $127M | $161M | $165M |
| EPS Avg | $3.83 | $4.85 | $5.01 |
| Low | $3.69 | $4.45 | $4.86 |
| High | $4.01 | $5.08 | $5.20 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $215M | $225M | $223M | $221M | $227M | $232M |
| Low | $215M | $224M | $222M | $220M | $226M | $231M |
| High | $215M | $226M | $223M | $221M | $227M | $232M |
| EBITDA Avg | $49M | $52M | $51M | $51M | $52M | $53M |
| Low | $49M | $52M | $51M | $51M | $52M | $53M |
| High | $49M | $52M | $51M | $51M | $52M | $53M |
| EBIT Avg | $46M | $48M | $48M | $47M | $49M | $50M |
| Low | $46M | $48M | $48M | $47M | $48M | $49M |
| High | $46M | $48M | $48M | $47M | $49M | $50M |
| Net Income Avg | $32M | $37M | $34M | $35M | $37M | $39M |
| Low | $31M | $36M | $34M | $35M | $37M | $39M |
| High | $34M | $37M | $34M | $35M | $37M | $39M |
| EPS Avg | $1.04 | $1.18 | $1.09 | $1.12 | $1.19 | $1.26 |
| Low | $0.99 | $1.17 | $1.09 | $1.11 | $1.18 | $1.26 |
| High | $1.09 | $1.18 | $1.09 | $1.12 | $1.19 | $1.27 |
| Analysts (Rev / EPS) | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |